Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

NCT07226999 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer (SCLC)

Interventions

DRUG: PF-08634404
BIOLOGICAL: Atezolizumab
DRUG: Chemotherapy

Sponsor

Pfizer